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Fura- loaded rat hepatocytes were used to determine whether the L-type channel blockers, verapamil and diltiazem, affect receptor-operated 
calcium channels (ROCCs). The flux through ROCCs was followed by quenching of fura- fluorescence due to the influx of extracellular Mn2’ 
induced by vasopressin. Verapamil as well as diltiazem inhibited vasopressin-stimulated Mn” influx in a dose-dependent manner up to 60% at 
concentrations of 2oo-400 ,uM. Furthermore, both inhibitors decreased significantly the frequency of phenylephrine-induced oscillation of [Ca”],. 
The experimental findings indicate that L-type channel blockers inhibit ROCCs in rat hepatocytes. 
Verapamil; Diltiazem; Receptor-operated Ca*’ channel; Fura-2; Calcium oscillation; Rat hepatocyte 
1. INTRODUCTION 
An increase of intracellular free calcium concentra- 
tion ([Ca2’],) was found to be caused by hormones, neu- 
rotransmitters, or membrane depolarisation. In excita- 
ble cells, voltage-dependent calcium channels (VDCCs) 
are responsible for the increase of [Ca2’], by the influx 
of extracellular Ca2’ across the plasma membrane [l]. 
In non-excitable cells, an increase of [Ca”], results: (i) 
from the activation of intracellular Ca” stores, such as 
endoplasmatic reticulum, via the phospholipase C- 
linked inositol 1,4,5trisphosphate cascade [24]; and 
(ii) from a receptor-mediated Ca2’ entry across the 
plasma membrane through receptor-operated Ca” 
channels (ROCCs) [5]. 
The quenching of fura- fluorescence by the vaso- 
pressin-stimulated influx of extracellular Mn2’ is an ap- 
propriate method for measuring flux rates through 
ROCCs [6]. Specific organic inhibitors for ROCCs are 
as yet not available, but it is well known that classical 
L-type VDCC blockers, like verapamil or diltiazem, 
influence liver metabolism, e.g. inhibit apolipoprotein 
B synthesis and secretion [7], inhibit bile acid synthesis 
[8], or inhibit c-myc expression in rat hepatocytes [9]. 
The reported effects of verapamil on Ca2’ entry in hepa- 
tocytes are controversial. Hughes et al. [lo] found a 
completely inhibited vasopressin-induced Ca2+ influx by 
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Hepatocytes from male Wistar rats (150-250 g, 24 h fasted) were 
prepared by collagenase H perfusion of liver according to Berry and 
Friend [l 11. For fura- loading and fluorescence measurement freshly 
isolated hepatocytes (> 85% intact cells with Trypan blue exclusion) 
were resuspended in Krebs-Henseleit medium saturated with 95% 
0*/S% COz, containing (in mM): glucose (lo), HEPES (lo), lactate 
(2.1), pyruvate (0.3). p-hydroxybutyrate (0.6). acetoacetate (0.3). and 
CaCl, (1.3). The cell suspension (4 mg protein per ml) was incubated 
with 10 PM fura-2/AM for 20 min at 37°C in a shaking water bath 
and for additional 20 min at room temperature, thereafter centrifuged 
(3OOxg. 1 min) and resuspended in the same medium without fura-2/ 
AM. The last step was repeated to wash out extracellular fura-2/AM. 
After this procedure, the intracellular fura- concentration was 6&80 
PM as estimated from the fluorescence intensities (340 nm excitation) 
of the cell suspension. Cellular autofluorescence of unloaded hepato- 
cytes accounted for < 15% of the total signal from fura- loaded 
hepatocytes. Loaded cells were stored at 0°C and used within 2 h. 
2.2. Measurement of Mr?’ in&x 
Abbreviations; ROCCs, receptor-operated Cal’ channels; [Ca”],, in- Fura- loaded cells were transferred in a continuously stirred quartz 
tracellular free calcium concentration; VDCCs, voltage-dependent 
Ca*’ channels. 
cuvette maintained at 30°C in a Sigma ZWSII dual wavelength spec- 
trophotometer. The fluorescence mission at the 340 nm and 360 nm 
measuring the initial rate of 45Ca2+ exchange, whereas 
Kass et al. [6] reported that verapamil did not affect the 
vasopressin-induced quenching of fura- fluorescence 
due to Mn2+ inflow. Therefore, we reinvestigated the 
influences of verapamil and diltiazem on agonist-stimu- 
lated Mn2’ inflow and studied their effects on the intra- 
cellular Ca2+ signal. 
2. MATERIALS AND METHODS 
[Arg’]-vasopressin, forskolin, verapamil and diltiazem were from 
Sigma (Deisenhofen, Germany). (-)-phenylephrine was from Serva 
(Heidelberg, Germany), fura-UAM and collagenase H were from 
Boehringer (Mannheim, Germany). All other chemicals were obtained 
from Merck (Dannstadt, Germany). 
2.1. Cell preparation andfura-2 loading 
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excitation wavelengths were recorded using a Schott KVSOO cutoff 
filter. The initial fluorescence intensities of the hepatocyte suspension 
were arbitrary set to 1 .O at 340 nm and to 0.6 at 360 nm excitation for 
all cell preparations in order to get comparable results independently 
of different intracellular fura- concentrations. 
Table I 
The influence of forskolin and of the sequence of additions on the 
effect of verapamil 
2.3. Measurement of [Ca”], 
Mn2’ influx 
(arbitrary unitslmin) 
1 ml of fura- loaded hepatocytes (0.4 mg protein per ml) was filled 
in a perifusion chamber mounted on the stage of an Olympus IMT-2 
inverted fluorescence microscope and allowed to attach to the cover 
slip on the bottom of the chamber for 5 min at room temperature. 
Perifusion media with and without effecters were maintained at 3O”C, 
saturated with 95% 0*/S% CO* and fed into the perifusion chamber 
by a peristaltic pump. The flow rate was 2 ml per min. The excitation 
wavelengths were 340 nm and 380 nm using appropriate interference 
filters in a Sutter Instruments filter wheel. The emission was set above 
500 nm by a dichroic mirror. Fluorescence images were obtained from 
a Hamamatsu C2400-87 intensified charge-coupled evice (CCD) 
camera. An IBM-compatible 386 computer digitized and stored the 
images. Ratio images (340 nm excitation/380 nm excitation) were 
calculated and analysed using the Olympus CUE/RMS software pack- 
age. 
Without forskolin 10 PM forskolin 
Control (without verapamil) 
Manganese before vasopressin 
Manganese after vasopressin 
17.6 k 0.7 
12.2 f 3.2 
9.9 f 1.5 
Experiments were performed as in Fig. 1. The data are the 
mean 2 S.E.M. from 3-5 experiments. n.d. = not determined. 
3. RESULTS 
The effect of verapamil on the vasopressin-induced 
fluorescence quenching due to the influx of extracellular 
Mn*+ is shown in Fig. 1. Whereas additions of vera- 
pamil and forskolin to fura- loaded hepatocytes did 
not affect the fluorescence at 340 nm excitation, indicat- 
ing no change of [Ca2+li, the addition of 500 ,uM MnCl, 






tion wavelengths (360 nm not shown). According to 
Kass et al. [6], this decrease is caused by the binding of 
Mn*’ to traces of extracellular fura-2. The initial Mn*‘- 
dependent quenching was followed by a slow further 
decrease in fluorescence due to an unspecific Mn*’ in- 
flux into the cell or a slow efflux of fura-2. Subsequent 
addition of 10 nM vasopressin markedly enhanced the 
fluorescence quenching by a stimulated influx of Mn’+ 
into hepatocytes (Fig. 1A) [6]. This vasopressin-induced 
quenching was distinctly inhibited by 200 PM verapamil 
(Fig. 1B). The inhibitory effect of verapamil did not 
depend on the presence of forskolin and a similar degree 
of inhibition was found if manganese was added after 
vasopressin (Table I). The inhibition was dose-depend- 
ent up to 60% at concentrations of 200400 PM (Fig. 
2A). Similar results were obtained with diltiazem (Fig. 
2B). The inhibition can be interpreted by a linear inhibi- 
tion model as demonstrated by a linear dixon plot (data 
not shown). The apparent K, for verapamil and dil- 
tiazem was 252 ,uM and 286 ,uM, respectively, from 
non-linear regression curves (Fig. 2). 
Verapamil 
In order to investigate whether verapamil or dil- 
tiazem really inhibit ROCCs we studied the influence of 
both inhibitors on intracellular calcium oscillations. 
Hepatocytes were stimulated with phenylephrine (< 5 
PM), resulting in an oscillatory change of the ratio sig- 
nal representing [Ca*‘], (Fig. 3). The addition of 200 PM 
Table II 
The influence of verapamil or diltiazem on calcium oscillations 
Frequency of n 
oscillation 
(spikes/l0 min) 
Fig, 1. Verapamil inhibited the vasopressin-induced fluorescence 
quenching of fura- loaded hepatocytes by the influx of extracellular 
Mn”. The figure shows the fluorescence intensity at 340 nm excita- 
tion. Additions were (A) 30 ~1 ethanol as control or (B) 200 PM 
verapamil dissolved in ethanol, 10 PM forskolin in order to produce 
a maximal response to vasopressin [6], 500 PM MnCl,, and 10 nM 
vasopressin. lated from Student’s paired r-test. 
Without verapamil 3.9 + 1.3 4 
200 PM verapamil 1 1 f 0.9 * 4 
Without diltiazem 9.0 + 1.8 5 
200 ,LLM diltiazem 3.5 f 2.0 *** 5 
Experiments were performed as in Fig. 3. The data are the 
mean f S.E.M. from n experiments. * P < 0.05, *** P < 0.001 calcu- 
342 
35.4 f 5.5 
16.2 t 5.1 
n.d. 
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Fig. 2. The effect of verapamil or diltiazem on agonist-stimulated Mn ‘+ influx was dose-dependent. Experiments were performed as in Fig. 1 with 
various concentrations of verapamil (A) or diltiazem (B). The equation y = V/(1+x/K,) was used for non-linear regression resulting in apparent 
K, = 252 PM or 286 PM for verapamil or diltiazem, respectively. Each point is the mean + S.E.M. of at least 5 incubations. 
verapamil or the same concentration of diltiazem dis- 
tinctly decreased the frequency of Ca” oscillations 
without influencing the amplitude of oscillation (Fig. 3 
and Table II). 
4. DISCUSSION 
This study demonstrates that verapamil as well as 
diltiazem are able to inhibit partly the vasopressin-stim- 
ulated Mn” influx at concentrations of 200-400 PM. 
For both inhibitors we estimated apparent Ki in the 
range of 200 PM. We conclude from these experiments 
that L-type channel blockers inhibit Ca*’ channels in 
the plasma membrane of hepatocytes which are possibly 
ROCCs. Our results are in agreement with the findings 
of Hughes et al. [lo]. These authors found a 50% inhibi- 
tion of the vasopressin-induced Ca2’ inflow by vera- 
pamil or nifedipine at concentrations of 50-100 PM by 
0 l,‘~~~~‘~“~‘,“~‘~‘~“~~~~” 
0 300 600 900 1200 1500 
TIME (sac) 
measuring the 45Ca2+ exchange and the activity of glyco- 
gen phosphorylase a. In contrast to us, Kass et al. [6] 
reported that the rates of Mn2’ influx after addition of 
vasopressin alone or in combination with glucagon were 
not changed by verapamil up to 200 ,uM. 
Glennon et al. [12] postulated in a recent paper that 
the increased agonist-induced quenching of hepatocytes 
loaded by the fura- ester was not an effect of the ag- 
onist on Mn*+ entry across the plasma membrane, but 
rather due to a penetration of Mn2’ into an intracellular 
organelle. This was concluded from a comparison to 
experiments with fura- injected cells where fura- was 
considered to be exclusively located in the cytosol. 
Three observations, in our opinion, are not in line with 
this interpretation and indicate that vasopressin-in- 
duced quenching results from Mn*+ inflow across the 
plasma membrane in fura-2/AM loaded cells, too. (i) 
Even Glennon et al. [12] found a stimulated Mn2’ entry 
B 
0 300 600 900 1200 1500 
TIME (sac) 
Fig. 3. Suppression of phenylephrine-induced oscillations of [Ca”], by (A) 200 pM verapamil or (B) 200 ,uM diltiazem. The figure shows the ratio 
signal (340 nm excitation/380 nm excitation) of one characteristic ell of one experiment with verapamil or diltiazem, respectively. The effect of 
decreased frequency was observed in all oscillatory cells (cf. Table II). 
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into fura- injected hepatocytes by vasopressin indicat- 
ing that the hormone activates channels in the plasma 
membrane. (ii) Comparable inhibitory effects on the 
influx rate of Mn” were observed if Mn2’ was added 
after vasopressin. In this case, an accumulation of Mn” 
prior to the addition of vasopressin, as argued by Glen- 
non et al. [12], is excluded, so that the monitored 
quenching must result from the flux of Mn2+ across the 
plasma membrane. (iii) The effect of verapamil or dil- 
tiazem on the frequency of vasopressin-induced Ca” 
oscillations, as reported here, corresponds to the re- 
moval of extracellular Ca” from the medium [ 131. After 
addition of the inhibitor, the first Ca2’ spike came in the 
normal time interval and thereafter the frequency of 
spikes was decreased. A possible explanation for this 
finding is that a hindered Ca’+ uptake into the cell 
caused by inhibited ROCCs delays the refilling of intra- 
cellular Ca2’ stores. Thus, a longer time interval is nec- 
essary for a new quanta1 Ca2+ release induced by inosi- 
to1 1,4,5_trisphosphate [14]. To our knowledge, this 
study shows for the first time the influence of Ca2’ 
channel blockers on oscillation of [Ca2’], in non-excita- 
ble cells. Taken together with the effects on Mn” 
quenching and other effects reported in the literature 
[7-91 we conclude that the L-type channel blockers in- 
hibit receptor-operated calcium channels in hepato- 
cytes. 
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